Low-level laser therapy for androgenetic alopecia
نویسندگان
چکیده
منابع مشابه
low level laser therapy for painful joints
low level laser therapy (lllt) uses a light source that generates extremely pure light, of a single wavelength1. the effect is not thermal, but rather related to photochemical reactions in the cells. lllt was introduced as an alternative non-invasive treatment for oa about 10 years ago, but its effectiveness is still controversial2. a cochrane review of lllt in osteoarthritis included five tria...
متن کاملLow-Level Laser Therapy
©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 20 Applies to all products admin...
متن کاملInflammation in androgenetic alopecia
Years of research have led to the conclusion that androgenetic alopecia may be a result of an alteration in the hair growth cycle and/or a premature aging of the pilosebaceous unit. The etiology of androgenetic alopecia has been defined as multifactorial or even polygenic in nature. The fact that the success rate of treatment with either antihypertensive agents or modulators of androgen metabol...
متن کاملMale androgenetic alopecia.
IMPORTANCE OF THE FIELD Androgenetic alopecia affects up to 80% of males by the age of 80. The synonym 'male-pattern hair loss' highlights the fact that hair loss occurs in a defined and reproducible pattern. Hair loss results in reduced self esteem, loss of confidence and anxiety in affected men. An effective treatment for hair baldness would be desirable. AREAS COVERED IN THIS REVIEW In and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Actas Dermo-Sifiliográficas (English Edition)
سال: 2021
ISSN: 1578-2190
DOI: 10.1016/j.adengl.2020.03.017